Treats interdigital tinea pedis caused by Trichophyton rubrum, Trichophyton…. NDA 205175, held by Resilia Pharms. Econazole Nitrate.
As of Nov 15, 2026, NDA 205175 (Ecoza), held by Resilia Pharms, was first approved by FDA on Oct 24, 2013, with 2 approved supplements and 0 published complete response letters.
Ecoza (econazole nitrate) topical foam, 1%, is indicated for the treatment of interdigital tinea pedis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum in patients 12 years of age and older.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 24, 2013 | Original applicationNew dosage form · Standard review | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ecoza1% · aerosol, foam;topical | Econazole Nitrate | RxReference drug |
| Nov 18, 2019 | Supplement 3Labeling · Standard review | Approved | |
| Aug 1, 2016 | Supplement 1Manufacturing · Standard review | Approved | None posted |
| Oct 24, 2013 | Original applicationNew dosage form · Standard review | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
